Arcutis Biotherapeutics
Price & Volume
Stats
See moreOpen | $23.93 |
Previous Close | $24.21 |
Day Range | $23.87-$24.49 |
52W Range | $12.42-$31.77 |
Market Cap | $3B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $376M |
Revenue Growth (YoY) | 81.5% |
Gross Profit (12 Mos) | $339.3M |
Diluted EPS | -$0.13 |
News
See moreYahoo Finance • 6 days ago
The Credibility Filter Wall Street Uses to Sort Biotech Winners
Yahoo Finance • 6 days ago
Arcutis Stock Up 65% as Director Sells 10,000 Shares Under 10b5-1 Plan. Here's What Investors Should Know
Yahoo Finance • 16 days ago
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
Yahoo Finance • last month
Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating
About
CEO | Mr. Todd Franklin Watanabe M.A. |
Address | 3027 Townsgate Road, Westlake Village, CA, United States, 91361 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 354 |
